Loutsou, M.; Dermitzaki, E.; Paparodis, R.D.; Michoula, A.N.; Angelopoulos, N.; Christopoulos, P.; Diamantopoulos, S.; Mastorakos, G.; Grivea, I.N.; Papadimitriou, D.T.
Dramatic Deterioration of Subclinical Hyperparathyroidism in Children and Adolescents During the Post-COVID-19 Period. Diseases 2025, 13, 198.
https://doi.org/10.3390/diseases13070198
AMA Style
Loutsou M, Dermitzaki E, Paparodis RD, Michoula AN, Angelopoulos N, Christopoulos P, Diamantopoulos S, Mastorakos G, Grivea IN, Papadimitriou DT.
Dramatic Deterioration of Subclinical Hyperparathyroidism in Children and Adolescents During the Post-COVID-19 Period. Diseases. 2025; 13(7):198.
https://doi.org/10.3390/diseases13070198
Chicago/Turabian Style
Loutsou, Maria, Eleni Dermitzaki, Rodis D. Paparodis, Aspasia N. Michoula, Nicholas Angelopoulos, Panagiotis Christopoulos, Stavros Diamantopoulos, George Mastorakos, Ioanna N. Grivea, and Dimitrios T. Papadimitriou.
2025. "Dramatic Deterioration of Subclinical Hyperparathyroidism in Children and Adolescents During the Post-COVID-19 Period" Diseases 13, no. 7: 198.
https://doi.org/10.3390/diseases13070198
APA Style
Loutsou, M., Dermitzaki, E., Paparodis, R. D., Michoula, A. N., Angelopoulos, N., Christopoulos, P., Diamantopoulos, S., Mastorakos, G., Grivea, I. N., & Papadimitriou, D. T.
(2025). Dramatic Deterioration of Subclinical Hyperparathyroidism in Children and Adolescents During the Post-COVID-19 Period. Diseases, 13(7), 198.
https://doi.org/10.3390/diseases13070198
